{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:38:42Z","timestamp":1789738722137,"version":"4.0.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T00:00:00Z","timestamp":1535414400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00259-018-4113-1","type":"journal-article","created":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T08:27:03Z","timestamp":1535531223000},"page":"324-333","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The relationship between CSF biomarkers and cerebral metabolism in early-onset Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4605-0575","authenticated-orcid":false,"given":"Alice","family":"Jaillard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Vanhoutte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lien","family":"Maureille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Schraen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Skrobala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Delbeuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Rollin-Sillaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Pasquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Bombois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Semah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,28]]},"reference":[{"key":"4113_CR1","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","volume":"5","author":"O Hansson","year":"2006","unstructured":"Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L. Association between CSF biomarkers and incipient Alzheimer\u2019s disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol. 2006;5:228\u201334.","journal-title":"Lancet Neurol"},{"key":"4113_CR2","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1212\/01.wnl.0000345014.48839.71","volume":"72","author":"AE Vlies van der","year":"2009","unstructured":"van der Vlies AE, Verwey NA, Bouwman FH, Blankenstein MA, Klein M, Scheltens P, et al. CSF biomarkers in relationship to cognitive profiles in Alzheimer disease. Neurology. 2009;72:1056\u201361.","journal-title":"Neurology"},{"key":"4113_CR3","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1212\/WNL.0b013e3181dd4dd8","volume":"74","author":"AK Wallin","year":"2010","unstructured":"Wallin AK, Blennow K, Zetterberg H, Londos E, Minthon L, Hansson O. CSF biomarkers predict a more malignant outcome in Alzheimer disease. Neurology. 2010;74:1531\u20137.","journal-title":"Neurology"},{"key":"4113_CR4","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1007\/s00259-012-2102-3","volume":"39","author":"R Ossenkoppele","year":"2012","unstructured":"Ossenkoppele R, Tolboom N, Foster-Dingley JC, Adriaanse SF, Boellaard R, Yaqub M, et al. Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET. Eur J Nucl Med Mol Imaging. 2012;39:990\u20131000.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4113_CR5","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1212\/01.wnl.0000244749.20056.d4","volume":"68","author":"P Edison","year":"2007","unstructured":"Edison P, Archer HA, Hinz R, Hammers A, Pavese N, Tai YF, et al. Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study. Neurology. 2007;68:501\u20138.","journal-title":"Neurology"},{"key":"4113_CR6","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1212\/WNL.0b013e3181bc010c","volume":"73","author":"WJ Jagust","year":"2009","unstructured":"Jagust WJ, Landau SM, Shaw LM, Trojanowski JQ, Koeppe RA, Reiman EM, et al. Relationships between biomarkers in aging and dementia. Neurology. 2009;73:1193\u20139.","journal-title":"Neurology"},{"key":"4113_CR7","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/MNM.0000000000000314","volume":"36","author":"A Chiaravalloti","year":"2015","unstructured":"Chiaravalloti A, Martorana A, Koch G, Toniolo S, di Biagio D, di Pietro B, et al. Functional correlates of t-tau, p-tau and A\u03b21-42 amyloid cerebrospinal fluid levels in Alzheimer\u2019s disease: a 18F-FDG PET\/CT study. Nucl Med Commun. 2015;36:461\u20138.","journal-title":"Nucl Med Commun"},{"key":"4113_CR8","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.nbd.2013.01.023","volume":"54","author":"J Dumurgier","year":"2013","unstructured":"Dumurgier J, Gabelle A, Vercruysse O, Bombois S, Laplanche J-L, Peoc\u2019h K, et al. Exacerbated CSF abnormalities in younger patients with Alzheimer\u2019s disease. Neurobiol Dis. 2013;54:486\u201391.","journal-title":"Neurobiol Dis"},{"key":"4113_CR9","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1177\/1533317512454711","volume":"27","author":"MF Mendez","year":"2012","unstructured":"Mendez MF, Lee AS, Joshi A, Shapira JS. Nonamnestic presentations of early-onset Alzheimer\u2019s disease. Am J Alzheimers Dis Other Demen. 2012;27:413\u201320.","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"4113_CR10","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1093\/brain\/awh539","volume":"128","author":"EJ Kim","year":"2005","unstructured":"Kim EJ, Cho SS, Jeong Y, Park KC, Kang SJ, Kang E, et al. Glucose metabolism in early onset versus late onset Alzheimer\u2019s disease: an SPM analysis of 120 patients. Brain. 2005;128:1790\u2013801.","journal-title":"Brain"},{"key":"4113_CR11","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3233\/JAD-170367","volume":"60","author":"Y Chen","year":"2017","unstructured":"Chen Y, Sillaire AR, Dallongeville J, Skrobala E, Wallon D, Dubois B, et al. Low prevalence and clinical effect of vascular risk factors in early-onset Alzheimer\u2019s disease. J Alzheimers Dis. 2017;60:1045\u201354.","journal-title":"J Alzheimers Dis"},{"key":"4113_CR12","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.neurobiolaging.2017.08.009","volume":"59","author":"M Vanhoutte","year":"2017","unstructured":"Vanhoutte M, Semah F, Rollin Sillaire A, Jaillard A, Petyt G, Kuchcinski G, et al. (18)F-FDG PET hypometabolism patterns reflect clinical heterogeneity in sporadic forms of early-onset Alzheimer\u2019s disease. Neurobiol Aging. 2017;59:184\u201396.","journal-title":"Neurobiol Aging"},{"key":"4113_CR13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:263\u20139.","journal-title":"Alzheimers Dement"},{"key":"4113_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1532-5415.1985.tb07109.x","volume":"33","author":"M Folstein","year":"1985","unstructured":"Folstein M, Anthony JC, Parhad I, Duffy B, Gruenberg EM. The meaning of cognitive impairment in the elderly. J Am Geriatr Soc. 1985;33:228\u201335.","journal-title":"J Am Geriatr Soc"},{"key":"4113_CR15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1080\/01688638108403130","volume":"3","author":"R Gardner","year":"1981","unstructured":"Gardner R, Oliver-Mu\u00f1oz S, Fisher L, Empting L. Mattis dementia rating scale: internal reliability study using a diffusely impaired population. J Clin Neuropsychol. 1981;3:271\u20135.","journal-title":"J Clin Neuropsychol"},{"key":"4113_CR16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1136\/jnnp.73.2.126","volume":"73","author":"J Lindeboom","year":"2002","unstructured":"Lindeboom J, Schmand B, Tulner L, Walstra G, Jonker C. Visual association test to detect early dementia of the Alzheimer type. J Neurol Neurosurg Psychiatry. 2002;73:126\u201333.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4113_CR17","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/00002093-199812000-00014","volume":"12","author":"F Lebert","year":"1998","unstructured":"Lebert F, Pasquier F, Souliez L, Petit H. Frontotemporal behavioral scale. Alzheimer Dis Assoc Disord. 1998;12:335\u20139.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"4113_CR18","doi-asserted-by":"publisher","first-page":"e68398","DOI":"10.1371\/journal.pone.0068398","volume":"8","author":"NBM Quental","year":"2013","unstructured":"Quental NBM, Brucki SMD, Bueno OFA. Visuospatial function in early Alzheimer\u2019s disease--the use of the visual object and space perception (VOSP) battery. PLoS One. 2013;8:e68398.","journal-title":"PLoS One"},{"key":"4113_CR19","unstructured":"Deloche, G, Hannequin D.. DO 80, Epreuve de d\u00e9nomination orale d'images [DO80: Eighty pictures: confrontation oral naming battery], 1997 Paris Les Editions du Centre de Psychologie."},{"key":"4113_CR20","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1192\/bjp.140.6.566","volume":"140","author":"CP Hughes","year":"1982","unstructured":"Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566\u201372.","journal-title":"Br J Psychiatry"},{"key":"4113_CR21","doi-asserted-by":"crossref","unstructured":"Vercruysse O, Paquet C, Gabelle A, Delbeuck X, Blanc F, Wallon D, et al. Relevance of Follow-Up in Patients with Core Clinical Criteria for Alzheimer Disease and Normal CSF biomarkers. Curr Alzheimer Res. 2018.","DOI":"10.2174\/1567205015666180110113238"},{"key":"4113_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1006\/nimg.1998.0395","volume":"9","author":"AM Dale","year":"1999","unstructured":"Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis. I Segmentation and surface reconstruction. NeuroImage. 1999;9:179\u201394.","journal-title":"NeuroImage"},{"key":"4113_CR23","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4","volume":"8","author":"B Fischl","year":"1999","unstructured":"Fischl B, Sereno MI, Tootell RB, Dale AM. High-resolution intersubject averaging and a coordinate system for the cortical surface. Hum Brain Mapp. 1999;8:272\u201384.","journal-title":"Hum Brain Mapp"},{"key":"4113_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuroimage.2009.06.060","volume":"48","author":"DN Greve","year":"2009","unstructured":"Greve DN, Fischl B. Accurate and robust brain image alignment using boundary-based registration. NeuroImage. 2009;48:63\u201372.","journal-title":"NeuroImage"},{"key":"4113_CR25","first-page":"904","volume":"39","author":"OG Rousset","year":"1998","unstructured":"Rousset OG, Ma Y, Evans AC. Correction for partial volume effects in PET: principle and validation. J Nucl Med. 1998;39:904\u201311.","journal-title":"J Nucl Med"},{"key":"4113_CR26","first-page":"192","volume":"45","author":"M Quarantelli","year":"2004","unstructured":"Quarantelli M, Berkouk K, Prinster A, Landeau B, Svarer C, Balkay L, et al. Integrated software for the analysis of brain PET\/SPECT studies with partial-volume-effect correction. J Nucl Med. 2004;45:192\u2013201.","journal-title":"J Nucl Med"},{"key":"4113_CR27","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1001\/archneurol.2009.59","volume":"66","author":"EC Petrie","year":"2009","unstructured":"Petrie EC, Cross DJ, Galasko D, Schellenberg GD, Raskind MA, Peskind ER, et al. Preclinical evidence of Alzheimer changes: convergent cerebrospinal fluid biomarker and Fluorodeoxyglucose positron emission tomography findings. Arch Neurol. 2009;66:632\u20137.","journal-title":"Arch Neurol"},{"key":"4113_CR28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0304-3940(99)00644-8","volume":"273","author":"N Okamura","year":"1999","unstructured":"Okamura N, Arai H, Higuchi M, Tashiro M, Matsui T, Itoh M, et al. Cerebrospinal fluid levels of amyloid beta-peptide1-42, but not tau have positive correlation with brain glucose metabolism in humans. Neurosci Lett. 1999;273:203\u20137.","journal-title":"Neurosci Lett"},{"key":"4113_CR29","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1007\/s00259-009-1063-7","volume":"36","author":"S Arlt","year":"2009","unstructured":"Arlt S, Brassen S, Jahn H, Wilke F, Eichenlaub M, Apostolova I, et al. Association between FDG uptake, CSF biomarkers and cognitive performance in patients with probable Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2009;36:1090\u2013100.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4113_CR30","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1159\/000218080","volume":"27","author":"R Vukovich","year":"2009","unstructured":"Vukovich R, Perneczky R, Drzezga A, F\u00f6rstl H, Kurz A, Riemenschneider M. Brain metabolic correlates of cerebrospinal fluid beta-amyloid 42 and tau in Alzheimer\u2019s disease. Dement Geriatr Cogn Disord. 2009;27:474\u201380.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"4113_CR31","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.brainres.2017.10.016","volume":"1678","author":"A Chiaravalloti","year":"2018","unstructured":"Chiaravalloti A, Barbagallo G, Ricci M, Martorana A, Ursini F, Sannino P, et al. Brain metabolic correlates of CSF tau protein in a large cohort of Alzheimer\u2019s disease patients: a CSF and FDG PET study. Brain Res. 2018;1678:116\u201322.","journal-title":"Brain Res"},{"key":"4113_CR32","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1212\/01.WNL.0000046581.81650.D0","volume":"60","author":"D Strozyk","year":"2003","unstructured":"Strozyk D, Blennow K, White LR, Launer LJ. CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study. Neurology. 2003;60:652\u20136.","journal-title":"Neurology"},{"key":"4113_CR33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239\u201359.","journal-title":"Acta Neuropathol"},{"key":"4113_CR34","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/cercor\/1.1.103","volume":"1","author":"SE Arnold","year":"1991","unstructured":"Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer\u2019s disease. Cereb Cortex 1991. 1991;1:103\u201316.","journal-title":"Cereb Cortex 1991"},{"key":"4113_CR35","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.1097\/00001756-199712220-00022","volume":"8","author":"T Tapiola","year":"1997","unstructured":"Tapiola T, Overmyer M, Lehtovirta M, Helisalmi S, Ramberg J, Alafuzoff I, et al. The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer\u2019s disease. Neuroreport. 1997;8:3961\u20133.","journal-title":"Neuroreport"},{"key":"4113_CR36","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1093\/brain\/aww027","volume":"139","author":"R Ossenkoppele","year":"2016","unstructured":"Ossenkoppele R, Schonhaut DR, Sch\u00f6ll M, Lockhart SN, Ayakta N, Baker SL, et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer\u2019s disease. Brain. 2016;139:1551\u201367.","journal-title":"Brain"},{"key":"4113_CR37","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","volume":"16","author":"H Braak","year":"1995","unstructured":"Braak H, Braak E. Staging of Alzheimer\u2019s disease-related neurofibrillary changes. Neurobiol Aging. 1995;16:271\u201384.","journal-title":"Neurobiol Aging"},{"key":"4113_CR38","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/WCO.0b013e32833be924","volume":"23","author":"DW Dickson","year":"2010","unstructured":"Dickson DW, Ahmed Z, Algom AA, Tsuboi Y, Josephs KA. Neuropathology of variants of progressive supranuclear palsy. Curr Opin Neurol. 2010;23:394\u2013400.","journal-title":"Curr Opin Neurol"},{"key":"4113_CR39","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1212\/WNL.0b013e3181d7d871","volume":"74","author":"D Renard","year":"2010","unstructured":"Renard D, Collombier L, Castelnovo G, Labauge P. Teaching NeuroImages: FDG-PET in progressive supranuclear palsy. Neurology. 2010;74:e60.","journal-title":"Neurology"},{"key":"4113_CR40","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1093\/brain\/awm177","volume":"130","author":"NL Foster","year":"2007","unstructured":"Foster NL, Heidebrink JL, Clark CM, Jagust WJ, Arnold SE, Barbas NR, et al. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer\u2019s disease. Brain. 2007;130:2616\u201335.","journal-title":"Brain"},{"key":"4113_CR41","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1093\/brain\/awu256","volume":"137","author":"M Niethammer","year":"2014","unstructured":"Niethammer M, Tang CC, Feigin A, Allen PJ, Heinen L, Hellwig S, et al. A disease-specific metabolic brain network associated with corticobasal degeneration. Brain. 2014;137:3036\u201346.","journal-title":"Brain"},{"key":"4113_CR42","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","volume":"9","author":"CR Jack","year":"2010","unstructured":"Jack CR, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, et al. Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade. Lancet Neurol. 2010;9:119\u201328.","journal-title":"Lancet Neurol"},{"key":"4113_CR43","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neulet.2007.03.064","volume":"419","author":"K Blennow","year":"2007","unstructured":"Blennow K, Zetterberg H, Minthon L, Lannfelt L, Strid S, Annas P, et al. Longitudinal stability of CSF biomarkers in Alzheimer\u2019s disease. Neurosci Lett. 2007;419:18\u201322.","journal-title":"Neurosci Lett"},{"key":"4113_CR44","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1126\/scitranslmed.aaf2362","volume":"8","author":"MR Brier","year":"2016","unstructured":"Brier MR, Gordon B, Friedrichsen K, McCarthy J, Stern A, Christensen J, et al. Tau and A\u03b2 imaging, CSF measures, and cognition in Alzheimer\u2019s disease. Sci Transl Med. 2016;8:338\u201366.","journal-title":"Sci Transl Med"},{"key":"4113_CR45","doi-asserted-by":"crossref","unstructured":"Alvarez JA, Emory E. Executive function and the frontal lobes: a meta-analytic review. Neuropsychol Rev. 2006;16:17\u201342.","DOI":"10.1007\/s11065-006-9002-x"},{"key":"4113_CR46","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.neuroimage.2006.07.036","volume":"33","author":"DJ Hagler","year":"2006","unstructured":"Hagler DJ, Saygin AP, Sereno MI. Smoothing and cluster thresholding for cortical surface-based group analysis of fMRI data. NeuroImage. 2006;33:1093\u2013103.","journal-title":"NeuroImage"},{"key":"4113_CR47","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/j.neuroimage.2012.06.019","volume":"63","author":"A Tucholka","year":"2012","unstructured":"Tucholka A, Fritsch V, Poline J-B, Thirion B. An empirical comparison of surface-based and volume-based group studies in neuroimaging. NeuroImage. 2012;63:1443\u201353.","journal-title":"NeuroImage"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-018-4113-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-018-4113-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-018-4113-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T19:09:11Z","timestamp":1566932951000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-018-4113-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,28]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["4113"],"URL":"https:\/\/doi.org\/10.1007\/s00259-018-4113-1","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,28]]},"assertion":[{"value":"12 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"- Alice Jaillard: Reports no disclosures.- Matthieu Vanhoutte: Reports no disclosures.- St\u00e9phanie Bombois: Reports no disclosures.- Aur\u00e9lien Maureille: Reports no disclosures.- Susanna Schraen: Reports no disclosures.- Emilie Skrobala: Reports no disclosures.- Xavier Delbeuck: Reports no disclosures.- Adeline Rollin-Sillaire: Reports no disclosures.- Florence Pasquier: Reports no disclosures.- Franck Semah: Reports no disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This research was an ancillary study of the COMAJ cohort, which has been approved by the corresponding local investigational review boards (CPP Nord-Ouest I, CPP Paris Piti\u00e9-Salp\u00eatri\u00e8re and CPP Ile-de-France II; reference: 110\u201305). All participants gave their written, informed consent to participation in the COMAJ study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}